Patent Assignment
Reel/Frame 022240/0332
Change of Name
Recorded: 2009-02-11
Received: 2009-02-11
Pages: 18
Assignor
SOCIETE DE CONSEILS DE RECHERCHES ET D'APPLICATIONS SCIENTIFIQUES, S.A.S.
Executed: 2008-11-28
Assignee
IPSEN PHARMA S.A.S.
65 QUAI GEORGES GORSE, BOULOGNE-BILLANCOURT, FRX, 92100, FRANCE
Covered Properties
(29)
Analogs of Parathyroid Hormone
Application:
11/684,383 →
Prenyl Transferase Inhibitors
Application:
11/353,518 →
Farnesyl Transferase Inhibitors
Application:
11/287,996 →
Somatostatin-Dopamine Chimeric Analogs
Application:
11/262,403 →
Analogues of Glp-1
Application:
11/145,782 →
Lactone Bearing Absorbable Polymers
Application:
11/114,452 →
Somatostatin Agonists
Application:
11/028,785 →
Method of Inhibiting Fibrosis with a Somatostatin Agonist
Application:
10/935,593 →
Imidazolyl Derivatives
Application:
10/771,725 →
Pharmaceutical Compositions Which Inhibit Vascular Proliferation and Method of Use Thereof
Application:
10/466,152 →
Analogues of Glp-1
Application:
10/629,261 →
Somatostatin and Somatostatin Agonists for Treating Insulin Insensitivity and Syndrome X
Application:
10/369,143 →
Analogs of Parathyroid Hormone
Application:
10/289,519 →
Farnesyl Transferase Inhibitors
Application:
10/273,735 →
Imidazolyl Derivatives
Application:
10/151,265 →
Sustained Release Formulation of a Peptide
Application:
10/048,856 →
Use of Ginkgo Extract
Application:
10/018,448 →
Neuromedin B and Somatostatin Receptor Agonists
Application:
09/980,133 →
Somatostatin Agonists
Application:
09/980,943 →
Ionic Molecular Conjugates of Biodegradable Polyesters and Bioactive Polypeptides
Application:
09/890,013 →
Analogues of Glp-1
Application:
09/857,636 →
Prenyl Transferase Inhibitors
Application:
09/868,356 →
Glp-1 Analogues
Application:
09/856,676 →
Lactone Bearing Absorbable Polymers
Application:
09/830,945 →
Beta-Carboline Compounds
Application:
09/719,455 →
Imidazolyl Derivatives
Application:
09/719,457 →
Imidazolyl Derivatives
Application:
09/719,720 →
Cyclic Somatostatin Analogs
Application:
09/719,784 →
Method of Inhibiting Fibrosis with a Somatostatin Agonist
Application:
09/761,605 →